A recent study using C13-glutamine performed in APP/PS1 mice suggests that reduced glutamine uptake and impaired oxidative glutamine metabolism could be very early markers of AD pathogenesis, as they precede the amyloid plaque formation in this model [49]. The gene discussed is APP; the disease is Alzheimer disease.